Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hillhouse Capital Holdings

3,100.22
+35.081.14%
Number of Gainers:49
Number of Losers:25
Number of Flat:1
PE:- -
High:3,108.76
Open:3,036.09
Low:3,036.07
Close:3,065.10
Loading ...

Positive Outlook for Blueprint Medicines Driven by Strong Ayvakit Performance and Pipeline Progress

TIPRANKS
·
49 mins ago

Uber, May Mobility Partner to Launch Autonomous Vehicles on Platform

MT Newswires Live
·
1 hour ago

Top Penny Stocks To Watch In May 2025

Simply Wall St.
·
1 hour ago

High Growth Tech Stocks In The US For May 2025

Simply Wall St.
·
2 hours ago

Uber Partners With May Mobility to Plans to Launch Autonomous Taxis

Dow Jones
·
2 hours ago

Kronos Bio Enters Deal to be Acquired by Concentra Biosciences; Shares Fall

MT Newswires Live
·
2 hours ago

Uber announces multi-year AV partnership with May Mobility

TIPRANKS
·
2 hours ago

Uber Technologies Inc. and May Mobility Forge Strategic Partnership to Launch Autonomous Vehicles in Arlington, Texas

Reuters
·
2 hours ago

Uber and May Mobility Announce Strategic Partnership to Scale Autonomous Vehicles

THOMSON REUTERS
·
2 hours ago

Uber Technologies Inc - and May Mobility to Expand to Additional U.S. Markets in 2026

THOMSON REUTERS
·
2 hours ago

Axsome Therapeutics (AXSM) Gets a Buy from Mizuho Securities

TIPRANKS
·
3 hours ago

Design Therapeutics Says Eye Drops for Fuchs Endothelial Corneal Dystrophy 'Well-Tolerated'

MT Newswires Live
·
3 hours ago

TransCode Therapeutics (NASDAQ: RNAZ) Advances Phase 1a Trial of RNA Cancer Therapy TTX-MC138

TIPRANKS
·
3 hours ago

Aurora Innovation Rolls Out Commercial Self-Driving Trucking Service in Texas

MT Newswires Live
·
Yesterday

Apple must pay Optis $502 million lump sum in UK patent dispute, court rules

Reuters
·
Yesterday

Press Release: Snowflake to Announce Financial Results for the First Quarter of Fiscal 2026 on May 21, 2025

Dow Jones
·
Yesterday

Kronos Bio Agrees to Be Acquired by Concentra Biosciences

Dow Jones
·
Yesterday

Lyell Immunopharma Announces Oral Presentation of New Clinical Data From the Phase 1/2 Trial of Lyl314 for the Treatment of Large B-Cell Lymphoma at the International Conference on Malignant Lymphoma (Icml) 2025

THOMSON REUTERS
·
Yesterday

Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025

GlobeNewswire
·
Yesterday

New Philips Norelco Shaver i9000 Prestige Ultra Introduces the Brand's First "Root-Level" Shave, for Closest Shave Yet

PR Newswire
·
Yesterday